<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37773838</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><Issue>39</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Global research hotspots and frontier trends of epigenetic modifications in autoimmune diseases: A bibliometric analysis from 2012 to 2022.</ArticleTitle><Pagination><StartPage>e35221</StartPage><MedlinePgn>e35221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e35221</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000035221</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Recent studies have shown substantial progress in understanding the association between epigenetics and autoimmune diseases. However, there is a lack of comprehensive bibliometric analysis in this research area. This article aims to present the current status and hot topics of epigenetic research in autoimmune diseases (ADs) from a bibliometric perspective, as well as explore the frontier hotspots and trends in epigenetic studies related to ADs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study collected 1870 epigenetic records related to autoimmune diseases from the web of science core collection database, spanning from 2012 to 2022. Analysis of regions, institutions, journals, authors, and keywords was conducted using CiteSpace, VOSviewer, and the R package "bibliometrix" to predict the latest trends in epigenetic research relevant to autoimmune diseases.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of epigenetic publications related to autoimmune diseases has been increasing annually. The United States has played a major role in this field, contributing over 45.9% of publications and leading in terms of publication volume and citation counts. Central South University emerged as the most active institution, contributing the highest number of publications. Frontiers in Immunology is the most popular journal in this field, publishing the most articles, while the Journal of Autoimmunity is the most co-cited journal. Lu QJ is the most prolific author, and Zhao M is the most frequently co-cited author. "Immunology" serves as a broad representative of epigenetic research in ADs. Hot topics in the field of epigenetic modifications associated with autoimmune diseases include "regulatory T cells (Treg)," "rheumatoid arthritis," "epigenetic regulation," "cAMPresponsive element modulator alpha," "cell-specific enhancer," "genetic susceptibility," and "systemic lupus erythematosus." Furthermore, the study discusses the frontiers and existing issues of epigenetic modifications in the development of autoimmune diseases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study provides a comprehensive overview of the knowledge structure and developmental trends in epigenetic research related to autoimmune diseases over the past 11 years.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yehui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Sheng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yongxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>International Education College, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xiaodan</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0006-5560-8816</Identifier><AffiliationInfo><Affiliation>Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015706" MajorTopicYN="N">Bibliometrics</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>15</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37773838</ArticleId><ArticleId IdType="pmc">PMC10545364</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000035221</ArticleId><ArticleId IdType="pii">00005792-202309290-00056</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zou Y, Xu S, Xiao Y, et al. . Long noncoding RNA LERFS negatively regulates rheumatoid synovial aggression and proliferation. J Clin Invest. 2018;128:4510&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6159954</ArticleId><ArticleId IdType="pubmed">30198906</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Pan YF, Xue YQ, et al. . uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis. Cell Mol Immunol. 2018;15:171&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5811678</ArticleId><ArticleId IdType="pubmed">28090093</ArticleId></ArticleIdList></Reference><Reference><Citation>Man&#xe9;-Damas M, Hoffmann C, Zong S, et al. . Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities. Autoimmun Rev. 2019;18:102348.</Citation><ArticleIdList><ArticleId IdType="pubmed">31323365</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh SJ, Rau LM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health. 2000;90:1463&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1447637</ArticleId><ArticleId IdType="pubmed">10983209</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Li S, Huang R, et al. . Comprehensive meta-analysis reveals an association of the HLA-DRB1*1602 allele with autoimmune diseases mediated predominantly by autoantibodies. Autoimmun Rev. 2020;19:102532.</Citation><ArticleIdList><ArticleId IdType="pubmed">32234402</ArticleId></ArticleIdList></Reference><Reference><Citation>Tkachenko O, Lapin S, Maslyansky A, et al. . Influence of HLA-DRB1 susceptibility alleles on the autoantibodies spectrum of systemic lupus erythematosus in European part of Russia. Autoimmun Rev. 2019;18:558&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30844554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lu Q, Chang C. Epigenetics in health and disease. Adv Exp Med Biol. 2020;1253:3&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">32445090</ArticleId></ArticleIdList></Reference><Reference><Citation>Surace AEA, Hedrich CM. The role of epigenetics in autoimmune/inflammatory disease. Front Immunol. 2019;10:1525. Published 2019 Jul 4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620790</ArticleId><ArticleId IdType="pubmed">31333659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Liao J, Li Q, et al. . Epigenetics as biomarkers in autoimmune diseases. Clin Immunol. 2018;196:34&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29574040</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zhang R. Epigenetics in autoimmune diseases: pathogenesis and prospects for therapy. Autoimmun Rev. 2015;14:854&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">26026695</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883932</ArticleId><ArticleId IdType="pubmed">20585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y, Li Y, Zhang Z, et al. . A bibliometric analysis using VOSviewer of publications on COVID-19. Ann Transl Med. 2020;8:816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396244</ArticleId><ArticleId IdType="pubmed">32793661</ArticleId></ArticleIdList></Reference><Reference><Citation>Arruda H, Silva ER, Lessa M, et al. . VOSviewer and bibliometrix. J Med Libr Assoc. 2022;110:392&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9782747</ArticleId><ArticleId IdType="pubmed">36589296</ArticleId></ArticleIdList></Reference><Reference><Citation>Dervi&#x15f; H. Bibliometric analysis using bibliometrix an R package. J Scientomet Res. 2019;8:156&#x2013;60.</Citation></Reference><Reference><Citation>Wu H, Tong L, Wang Y, et al. . Bibliometric analysis of global research trends on ultrasound microbubble: a quickly developing field. Front Pharmacol. 6466;12:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101552</ArticleId><ArticleId IdType="pubmed">33967783</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad P, Slots J. A bibliometric analysis of periodontology. Periodontol 2000. 2021;85:237&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">33226679</ArticleId></ArticleIdList></Reference><Reference><Citation>Higaki A, Uetani T, Ikeda S, et al. . Co-authorship network analysis in cardiovascular research utilizing machine learning (2009&#x2013;2019). Int J Med Inform. 1042;143:74.</Citation><ArticleIdList><ArticleId IdType="pubmed">32987350</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo CM, Long TM. Document co-citation analysis to enhance transdisciplinary research. Sci Adv. 2018;4:e1701130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752411</ArticleId><ArticleId IdType="pubmed">29308433</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci USA. 2004;101:5303&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC387312</ArticleId><ArticleId IdType="pubmed">14724295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C. I.I. CiteSpace: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57:359&#x2013;77.</Citation></Reference><Reference><Citation>van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2883932</ArticleId><ArticleId IdType="pubmed">20585380</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L, Chen Z, Wang H, et al. . Bibliometric and visualized analysis of scientific publications on atlantoaxial spine surgery based on Web of Science and VOSviewer. World Neurosurg. 2020;137:435&#x2013;442.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">32006737</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurano MT, Humbert R, Rynes E, et al. . Systematic localization of common disease-associated variation in regulatory DNA. Science. 2012;337:1190&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3771521</ArticleId><ArticleId IdType="pubmed">22955828</ArticleId></ArticleIdList></Reference><Reference><Citation>Maecker HT, McCoy JP, Nussenblatt R. Standardizing immunophenotyping for the Human Immunology Project. Nat Rev Immunol. 2012;12:191&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409649</ArticleId><ArticleId IdType="pubmed">22343568</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MM. Immunology taught by humans. Sci Transl Med. 2012;4:117fs&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3762495</ArticleId><ArticleId IdType="pubmed">22261029</ArticleId></ArticleIdList></Reference><Reference><Citation>Farh KK, Marson A, Zhu J, et al. . Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature. 2015;518:337&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4336207</ArticleId><ArticleId IdType="pubmed">25363779</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">15032588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cepika AM, Sato Y, Liu JM, et al. . Tregopathies: monogenic diseases resulting in regulatory T-cell deficiency. J Allergy Clin Immunol. 2018;142:1679&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">30527062</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Liu S, Luo S, et al. . DNA methylation and mRNA and microRNA expression of SLE CD4+ T cells correlate with disease phenotype. J Autoimmun. 2014;54:127&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">25091625</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun. 2017;83:31&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">28342734</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JK, Jang YJ, Oh BR, et al. . Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis. Arthritis Res Ther. 2020;22:176. Published 2020 Jul 25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7382061</ArticleId><ArticleId IdType="pubmed">32711562</ArticleId></ArticleIdList></Reference><Reference><Citation>Trivedi T, Pagnotti GM, Guise TA, et al. . The role of TGF-&#x3b2; in bone metastases. Biomolecules. 2021;11:1643. Published 2021 Nov 6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8615596</ArticleId><ArticleId IdType="pubmed">34827641</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang SY, Alliston T. Regulation of postnatal bone homeostasis by TGF&#x3b2;. Bonekey Rep. 2013;2:255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3722719</ArticleId><ArticleId IdType="pubmed">24404376</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau JM, Velegraki M, Bolyard C, et al. . Transforming growth factor-&#x3b2;1 in regulatory T cell biology. Sci Immunol. 2022;7:eabi4613.</Citation><ArticleIdList><ArticleId IdType="pubmed">35302863</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi F, Franza L, Carusi V, et al. . Interleukin-6 in rheumatoid arthritis. Int J Mol Sci. 2020;21:5238. Published 2020 Jul 23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7432115</ArticleId><ArticleId IdType="pubmed">32718086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo N, Kuroda T, Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int J Mol Sci. 2021;22:10922. Published 2021 Oct 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8539723</ArticleId><ArticleId IdType="pubmed">34681582</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinocca C, Rizzo C, Fasano S, et al. . Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview. Front Immunol. 2021;12:637829. Published 2021 Feb 22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7937623</ArticleId><ArticleId IdType="pubmed">33692806</ArticleId></ArticleIdList></Reference><Reference><Citation>Karsdal MA, Madsen SH, Christiansen C, et al. . Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther. 2008;10:R63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2483454</ArticleId><ArticleId IdType="pubmed">18513402</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MC, Manning HB, Jain A, et al. . Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum. 2009;60:686&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2819053</ArticleId><ArticleId IdType="pubmed">19248098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabeh F, Fox D, Weiss SJ. Membrane-type I matrix metalloproteinase-dependent regulation of rheumatoid arthritis synoviocyte function. J Immunol. 2010;184:6396&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">20483788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mei X, Zhang B, Zhao M, et al. . An update on epigenetic regulation in autoimmune diseases. J Transl Autoimmun. 2022;5:100176. Published 2022 Dec 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9762196</ArticleId><ArticleId IdType="pubmed">36544624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C, Li D, Teng D, et al. . Epigenetic regulation in the pathogenesis of rheumatoid arthritis. Front Immunol. 2022;13:859400. Published 2022 Mar 24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8989414</ArticleId><ArticleId IdType="pubmed">35401513</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Q, Li H, Liu Y, et al. . Epigenetic regulation of immune and inflammatory responses in rheumatoid arthritis. Front Immunol. 2022;13:881191. Published 2022 Apr 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9035598</ArticleId><ArticleId IdType="pubmed">35479077</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Chen S, Li A, et al. . LncRNA expression profiles in systemic lupus erythematosus and rheumatoid arthritis: emerging biomarkers and therapeutic targets. Front Immunol. 2021;12:792884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8732359</ArticleId><ArticleId IdType="pubmed">35003113</ArticleId></ArticleIdList></Reference><Reference><Citation>Kyttaris VC, Wang Y, Juang YT, et al. . CAMP response element modulator a expression in patients with systemic lupus erythematosus. Lupus. 2006;15:840&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">17211988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, et al. . New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12:716&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129255</ArticleId></ArticleIdList></Reference><Reference><Citation>Krueger JG, Fretzin S, Su&#xe1;rez-Fari&#xf1;as M, et al. . IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. J Allergy Clin Immunol. 2012;130:145&#x2013;54.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3470466</ArticleId><ArticleId IdType="pubmed">22677045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich CM, Crispin JC, Rauen T, et al. . cAMP response element modulator &#x3b1; controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci USA. 2012;109:16606&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3478624</ArticleId><ArticleId IdType="pubmed">23019580</ArticleId></ArticleIdList></Reference><Reference><Citation>Rauen T, Hedrich CM, Tenbrock K, et al. . cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol Med. 2013;19:262&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891595</ArticleId><ArticleId IdType="pubmed">23491535</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedrich CM, Crispin JC, Tsokos GC. Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells. Autoimmunity. 2014;47:234&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">24762298</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Amarasinghe HE, Whalley JP, et al. . Epigenomic analysis reveals a dynamic and context-specific macrophage enhancer landscape associated with innate immune activation and tolerance. Genome Biol. 2022;23:136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9229144</ArticleId><ArticleId IdType="pubmed">35751107</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecellier CH, Wasserman WW, Mathelier A. Human enhancers harboring specific sequence composition, activity, and genome organization are linked to the immune response. Genetics. 2018;209:1055&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6063234</ArticleId><ArticleId IdType="pubmed">29871881</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong L, Wu F, Wu Q, et al. . Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming. Nat Commun. 2019;10:335.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6338783</ArticleId><ArticleId IdType="pubmed">30659195</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou G, Harley ITW, Lu X, et al. . SLE non-coding genetic risk variant determines the epigenetic dysfunction of an immune cell specific enhancer that controls disease-critical microRNA expression. Nat Commun. 2021;12:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794586</ArticleId><ArticleId IdType="pubmed">33420081</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarroll SA, Huett A, Kuballa P, et al. . Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn&#x2019;s disease. Nat Genet. 2008;40:1107&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2731799</ArticleId><ArticleId IdType="pubmed">19165925</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini D, Antonucci M, Petrelli F, et al. . One year in review 2020: pathogenesis of rheumatoid arthritis[J]. Clin Exp Rheumatol, 2020;38:387&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">32324123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysocki T, Olesi&#x144;ska M, Paradowska-Gorycka A. Current understanding of an emerging role of HLA-DRB1 gene in rheumatoid arthritis&#x2013;from research to clinical practice[J]. Cells. 2020;9:1127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291248</ArticleId><ArticleId IdType="pubmed">32370106</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran CS, Gupta S, Sanz I, et al. . PD-1 immunobiology in systemic lupus erythematosus[J]. J Autoimmun. 2019;97:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7449827</ArticleId><ArticleId IdType="pubmed">30396745</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai E, Wakeland EK. Genetic predisposition to autoimmunity--what have we learned? Semin Immunol. 2011;23:67&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">21288738</ArticleId></ArticleIdList></Reference><Reference><Citation>Javierre BM, Fernandez AF, Richter J, et al. . Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 2010;20:170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2813473</ArticleId><ArticleId IdType="pubmed">20028698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballestar E. Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol. 2011;7:263&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">21343899</ArticleId></ArticleIdList></Reference><Reference><Citation>Long H, Yin H, Wang L, et al. . The critical role of epigenetics in systemic lupus erythematosus and autoimmunity. J Autoimmun. 2016;74:118&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27396525</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Li X, Qin H, et al. . Ultraviolet B enhances DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus via inhibiting DNMT1 catalytic activity. J Dermatol Sci. 2013;71:167&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">23706494</ArticleId></ArticleIdList></Reference><Reference><Citation>Quddus J, Johnson KJ, Gavalchin J, et al. . Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest. 1993;92:38&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC293525</ArticleId><ArticleId IdType="pubmed">7686923</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X-x, Yan X-y, Zhong Y-l, et al. . Wnt/beta-catenin signaling pathway regulates the differentiation of mesenchymal stem cells into epithelial cells in the treatment of chronic obstructive pulmonary disease. J Clin Rehabil Tissue Eng Res. 2018;22:4089&#x2013;94.</Citation></Reference><Reference><Citation>Qiu W, Yun L. DNA methylation of the MHC region in rheumatoid arthritis: perspectives and challenges. J Rheumatol. 1597;47:1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">33139520</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Liu J, Huang C, et al. . Comprehensive analysis and functional characteristics of differential expression of N6-methyladenosine methylation modification in the whole transcriptome of rheumatoid arthritis. Mediators Inflamm. 2022;2022:4766992.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9626244</ArticleId><ArticleId IdType="pubmed">36330380</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgiou P, Maroulakou I, Green J, et al. . Expression of ets family of genes in systemic lupus erythematosus and Sjogren&#x2019;s syndrome. Int J Oncol. 1996;9:9&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21541474</ArticleId></ArticleIdList></Reference><Reference><Citation>Paramasivam A, Priyadharsini JV, Raghunandhakumar S. Implications of m6A modification in autoimmune disorders. Cell Mol Immunol. 2020;17:550&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7192904</ArticleId><ArticleId IdType="pubmed">31649306</ArticleId></ArticleIdList></Reference><Reference><Citation>Garo LP, Murugaiyan G. Contribution of MicroRNAs to autoimmune diseases. Cell Mol Life Sci. 2016;73:2041&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">26943802</ArticleId></ArticleIdList></Reference><Reference><Citation>Imgenberg-Kreuz J, Carlsson Alml&#xf6;f J, Leonard D, et al. . DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018;77:736&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909746</ArticleId><ArticleId IdType="pubmed">29437559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammaker D, Whitaker JW, Maeshima K, et al. . LBH gene transcription regulation by the interplay of an enhancer risk allele and DNA methylation in rheumatoid arthritis. Arthritis Rheumatol. 2016;68:2637&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5083131</ArticleId><ArticleId IdType="pubmed">27159840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Wei A, Zhang Y, et al. . Association between genetic variants of microRNA-21 and microRNA-155 and systemic lupus erythematosus: a case-control study from a Chinese population. J Clin Lab Anal. 2022;36:e24518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9279951</ArticleId><ArticleId IdType="pubmed">35707883</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagakis E, Bertsias G, Verginis P, et al. . Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis. 2011;70:1496&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">21602271</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng RX, Pan HF, Qin WZ, et al. . Role of microRNA-155 in autoimmunity. Cytokine Growth Factor Rev. 2011;22:141&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21703910</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Xu B, He J, et al. . Hypermethylation of Smad7 in CD4+ T cells is associated with the disease activity of rheumatoid arthritis. Front Immunol. 2023;14:1104881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9947360</ArticleId><ArticleId IdType="pubmed">36845150</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Wang H, Ba X, et al. . Decipher manifestations and Treg/Th17 imbalance in multi-staging rheumatoid arthritis and correlation with TSDR/RORC methylation. Mol Immunol. 2020;127:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32866740</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, Lin YC, Wu CC, et al. . The immunomodulatory effects of TNF-&#x3b1; inhibitors on human Th17 cells via ROR&#x3b3;t histone acetylation. Oncotarget. 2017;8:7559&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5352343</ArticleId><ArticleId IdType="pubmed">27926504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam P, Sharma A, Bhatnagar A. Global histone modification analysis reveals hypoacetylated H3 and H4 histones in B Cells from systemic lupus erythematosus patients. Immunol Lett. 2021;240:41&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">34614442</ArticleId></ArticleIdList></Reference><Reference><Citation>Fali T, Le Dantec C, Thabet Y, et al. . DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity. 2014;47:265&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4034120</ArticleId><ArticleId IdType="pubmed">24117194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackensen A, M&#xfc;ller F, Mougiakakos D, et al. . Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28:2124&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">36109639</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychaudhuri S, Sandor C, Stahl EA, et al. . Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44:291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3288335</ArticleId><ArticleId IdType="pubmed">22286218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi Y, Absher DM, Gulzar ZG, et al. . DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res. 2011;21:1017&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3129245</ArticleId><ArticleId IdType="pubmed">21521786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperini B, Visconti VV, Ciccacci C, et al. . Role of the Vitamin D Receptor (VDR) in the pathogenesis of osteoporosis: a genetic, epigenetic and molecular pilot study. Genes (Basel). 2023;14:542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10048253</ArticleId><ArticleId IdType="pubmed">36980815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>